Product Description:
Due to the normally aggressive nature of small cell cancer, I would recommend buying a supply of Celladam and Vitacell that would last approximately four months. I feel there is little point in ordering a year’s supply at this stage as the patient may unfortunately not respond to the products.
The dosage will obviously depend upon the recommendation of the doctors at Celladam. This will vary according to the medical information you have provided on the Checkout Confirmation page. However, I have been advised that in the majority of cases the initial dosage will be one injection of Celladam per week and 10 drops of Vitacell per day, except on the day when the injection is administered and the day after the injection. The Vitacell drops are taken orally, but because of the bitter taste you may use a sugar lump or anything you prefer to take the bitterness away.
If you feel the Celladam and Vitacell are benefiting you, since delivery can take up to fourteen days, please reorder your next pack in plenty of time to ensure a continued treatment plan.
The Starter Pack will include:
4 x Vials of Vitacell @ 18 EUR/vial = 72EUR
20 x Ampoules of Celladam injections @ 21 EUR/ampoule = 420EUR
Total Cost of Starter Pack = 492 EUR +p&p (35 EUR) = 527EUR
Please note; DO NOT take these treatments while you are undergoing chemotherapy or radiation treatment, as they will be of no benefit during these times.
I have found that these products, while they are not a cure for small cell cancer, have given me a very high quality of life at a minimal cost since I was diagnosed three and a half years ago.
CELLADAM
What is CELLADAM®?
The CELLADAM® trade mark originally designated a multicomponent pharmacological agent, but now it is the name of a complete medical system, having the following main elements: prevention, therapy.
These elements together comprise the system, what is called full service.
CELLADAM® is a „biological response modifier”. It has an antitumour-effect, it makes tumor-necrosis, it reduces the tumour-cell poliferation, it has an anti-metastasis effect. It is an immune stimulant, immune modulant, kalmoduline antagonist. It influences the differentiation of cells, their relation of electric charges, reorganises the malignant transformed cell’s cytosceletonic structure’s actin filamentums. It enhances the plasticity of the red blood-corpuscles, increases their filtration and decreases their thrombocyte aggregation, it is also an antioxidant and roborant.
What is CELLADAM® indicated for?
Since the very begining, the research on CELLADAM® has been aimed at the therapy of cancerous diseases. This application has been throughoutly researched, therefore it is in its present form suggested in the therapy of malignous tumours.
While the agent CELLADAM® is an efficient means of prevention in the early stage of cancer, it is still impeding the malignant processes and has an analgesic effect in hopeless state of a developed tumour.
The philosophy of CELLADAM® agents
The effect of CELLADAM® agents is best understood by examining the information flow among the cells. Looking from this approach, the cancerous cells are independent from their environment, the intercellular communication ceases, the cell builds a shell around itself (mask) , and cell multiplication becomes uncontrolled. The deviant cells intensively aquire the energy and the elements necessary for their sustainment.
CELLADAM® products try to restore the failed communications between the cancerous cell and its environment. How it is done?
Both CELLADAM® agents are capable of demasking the cancerous cells by their membrane-active effect. Symbolically speaking, the mask of the cancerous cell is removed, so it becomes recognizable for the immune system of the organizm.
The anti poliferation effect of the CELLADAM® agent on the one hand helps to restore the communication link with the healthy cells in the environment, on the other hand it impedes the multiplication of the cancerous cells. If the restoration is successful, the originally cancerous cell by differentiating becomes capable of functioning like the other cells in its environment, i.e. it heals. If restoration of the communication fails, e.g. due to very strong deviance, the immune system extincts the deviant cell and removes it from the organism.
Other CELLADAM® features
Further to the above therapeutical effects, a very important feature of the CELLADAM® agents is their analgesic effect, which is exerted to the very end of the cancerous process. Narcotic drugs are not needed at all or hardly needed, the patient’s disposition is improving, his/her general state is more human.
Last but not least, CELLADAM® is not toxic, not even at the manifold of the therapeutic dose.
CELLADAM® products:
Injections: 1 phial /2 ml/ = 2 mg active ingredient
You have to dilute up to 10 ml NaCl for intravein administration; it must be administered very slowly.
Generally it is useful for the treatment of cancerous diseases.
Suppositories: 1 supp. = 2.5 mg active ingredient
When the submission of injection is not recommended. It also can be useful in the case of colitis ulcerosa.
Vitacell drops: 1 ml = 10 mg active ingredient
It can be useful for preventing or treating cancerous diseases. Everybody (who is older than 18) can use it for strengthening the immune system of the organizm so diseases and any infections harder can be caught. It also relieves or brings the allergic symptoms to an end.
Cream: 1 container = 30 mg active ingredient
Malignant neoplasy, praeblastomatosis, autoimmune and allergic cases, ekcema, psoriasis and other dermatological illnesses, geriatric cases.
Contraindication:
Hypersensitivity to active ingredient.
Side effects:
Very rarely in case of administering Celladam iv. injections too quickly-hot flushes and dyspnoe can occur.
Celladam iv. injection could be followed by shivering, fever. This is a contraindication. No more injection should be given.
In case of lung tumours sometimes a cough occurs after 1 hour of administering Celladam iv. injections. This could be prevented by lowering the dosage.
Drug interactions:
Patients treated with Syncumar need to lower their Syncumar dosage, as Celladam is a mild anticoagulant.
Warning:
Sometimes Celladam drops cause dryness of the mouth. After radiotherapy on the head, neck or the inside of the mouth, in case of inflammation or tumour in the mouth or gingiva could contraindicate the use of Celladam drops.
In case of stoma no suppository should be given.
Serum Ca should be tested every 6 months. Miacalcic /osteochin/ could only followed by Celladam treatment after the interval of min. 12 hours.
Comment:
In case of cytostatic or radiation treatment Celladam should be stopped 2 days before and only started 2 days after the treatment was finished.
Celladam does not work when taking corticosteroids.
Celladam treatment should only be used medical supervision.
